What is EVH's health score?

Evolent Health, Inc. (EVH) has a TradeApes health score of 42 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is EVH's estimated fair value?

Based on our 5-year discounted cash flow model, Evolent Health, Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is EVH undervalued or overvalued?

Our model currently rates EVH as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for EVH... Refresh in a moment for the full analysis.

Evolent Health, Inc. (EVH)

Industrials Inconclusive inconclusive weak

$4.22

Updated: 2026-06-06

TradeApes Score

Financial Strength

35 Weak

Operating Trend

30 Weak

Relative Value

55 Mixed

Capital Allocation

60 Healthy

Risk

30 Weak

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.